Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Abilify oral solution 0.1% to be launched in Japan in April

March 26, 2009

Novel pyrazoloquinoline and pyrazolonaphthyridine derivatives claimed by Novartis

March 26, 2009

Novel GABA(A) modulator shows antinociceptive activity in vivo

March 26, 2009

Lilly presents novel gamma-secretase inhibitors

March 25, 2009

Epiphany Biosciences to file IND to study valomaciclovir adjunctive therapy in MS

March 25, 2009

Novel histamine H3 receptor antagonists claimed in AstraZeneca patent

March 25, 2009

Oxcarbazepine reduces pain in Parkinson's disease patients

March 25, 2009

Roche presents novel pyrrolodine aryl-ether compounds

March 24, 2009

Exalgo extended-release meets primary efficacy endpoint in phase III trial

March 24, 2009

FDA approves Symbyax for treatment-resistant depression

March 24, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026